[go: up one dir, main page]

AU570929B2 - Broad spectrum influenza antisera - Google Patents

Broad spectrum influenza antisera

Info

Publication number
AU570929B2
AU570929B2 AU19471/83A AU1947183A AU570929B2 AU 570929 B2 AU570929 B2 AU 570929B2 AU 19471/83 A AU19471/83 A AU 19471/83A AU 1947183 A AU1947183 A AU 1947183A AU 570929 B2 AU570929 B2 AU 570929B2
Authority
AU
Australia
Prior art keywords
terminus
peptide
amino acid
amino
acid residue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU19471/83A
Other languages
English (en)
Other versions
AU1947183A (en
Inventor
Stephen Alexander
Nicola Green
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scripps Research Institute
Original Assignee
Scripps Clinic and Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Clinic and Research Foundation filed Critical Scripps Clinic and Research Foundation
Publication of AU1947183A publication Critical patent/AU1947183A/en
Application granted granted Critical
Publication of AU570929B2 publication Critical patent/AU570929B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K16/108—
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU19471/83A 1982-08-23 1983-08-23 Broad spectrum influenza antisera Ceased AU570929B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41045582A 1982-08-23 1982-08-23
US410455 1982-08-23

Publications (2)

Publication Number Publication Date
AU1947183A AU1947183A (en) 1984-03-07
AU570929B2 true AU570929B2 (en) 1988-03-31

Family

ID=23624803

Family Applications (1)

Application Number Title Priority Date Filing Date
AU19471/83A Ceased AU570929B2 (en) 1982-08-23 1983-08-23 Broad spectrum influenza antisera

Country Status (16)

Country Link
EP (1) EP0116629A4 (fr)
JP (1) JPS59501714A (fr)
KR (1) KR840006198A (fr)
AU (1) AU570929B2 (fr)
DK (1) DK203684D0 (fr)
ES (1) ES8505819A1 (fr)
FI (1) FI841583A7 (fr)
GR (1) GR78931B (fr)
IL (1) IL69556A (fr)
IT (1) IT1168636B (fr)
NO (1) NO161002C (fr)
NZ (2) NZ220612A (fr)
PH (1) PH18872A (fr)
PT (1) PT77230B (fr)
WO (1) WO1984000687A1 (fr)
ZA (1) ZA836080B (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR241713A1 (es) * 1984-08-30 1992-11-30 Smithkline Beckman Corp Molecula de dna con una secuencia de bases que codifica la proteina c13 y preparacion de vacunas contra la gripe.
US5866363A (en) 1985-08-28 1999-02-02 Pieczenik; George Method and means for sorting and identifying biological information
KR910700259A (ko) * 1989-01-12 1991-03-14 리차드 이. 림바크 T-세포 인지성 펩티드 변형에 의해 면역반응에 영향을 주는 방법
EP0621339B1 (fr) * 1992-09-17 2001-10-24 Takara Shuzo Co. Ltd. Polypeptides immunogès dérivées du haemagglutinen de virus de la influenza type A humain
JP2996864B2 (ja) * 1994-03-30 2000-01-11 寳酒造株式会社 抗体可変領域ｄｎａ
EP2522678A1 (fr) * 2006-05-15 2012-11-14 Sea Lane Biotechnologies, LLC Anticorps neutralisants des virus de la grippe
US8148085B2 (en) 2006-05-15 2012-04-03 Sea Lane Biotechnologies, Llc Donor specific antibody libraries
EA017203B1 (ru) * 2006-09-07 2012-10-30 Круселл Холланд Б.В. Связывающие молекулы человека, способные нейтрализовать вирус гриппа h5n1, и их применение
ITTO20070066A1 (it) 2007-01-30 2008-07-31 Pomona Biotechnologies Llc Anticorpi monoclonali anti-idiotipo mimotopi dell'antigene gp 120 di hiv
CA2680237C (fr) 2007-03-27 2018-11-06 Sea Lane Biotechnologies, Llc Constructions et bibliotheques comprenant des sequences de chaines legeres de substitution d'anticorps
ITTO20080204A1 (it) 2008-03-17 2009-09-18 Pomona Biotechnologies Llc Anticorpi monoclonali atti a reagire con una pluralita di sottotipi del virus influenzale a
CA2719201A1 (fr) 2008-03-28 2009-10-01 Sea Lane Biotechnologies, Llc. Molecules neutralisantes d'antigenes viraux
ITTO20080398A1 (it) 2008-05-27 2009-11-28 Pomona Biotechnologies Llc Anticorpi monoclonali aventi proprieta' di cross-neutralizzazione omosubtipica per virus influenzali di tipo a sottotipo h1
ITTO20080964A1 (it) 2008-12-22 2010-06-23 Natimab Therapeutics S R L Anticorpo monoclonale anti-hcv come medicamento per il trattamento terapeutico e la prevenzione di infezioni da hcv
WO2010073647A1 (fr) 2008-12-25 2010-07-01 国立大学法人大阪大学 Anticorps humain anti-virus de la grippe humaine
EP3009145A1 (fr) 2009-03-30 2016-04-20 Mount Sinai School of Medicine of New York University Vaccins pour le virus influenza et leurs utilisations
CN102482345A (zh) * 2009-05-13 2012-05-30 航道生物技术有限责任公司 针对流感病毒的中和分子
JP5941841B2 (ja) 2009-05-26 2016-06-29 アイカーン スクール オブ メディシン アット マウント サイナイ 周期的投与によって作製されたインフルエンザウイルスに対するモノクローナル抗体及びその使用
IT1395961B1 (it) 2009-06-01 2012-11-02 Pomona Biotechnologies Llc Anticorpi monoclonali come medicamento per il trattamento terapeutico e/o profilattico delle infezioni da virus influenzale a (h1n1) di origine suina (s-oiv)
BR112012020839A2 (pt) * 2010-02-18 2017-11-21 Sinai School Medicine vacinas para uso na profilaxe e tratamento de doença de vírus da influenza
CN102939103A (zh) 2010-03-30 2013-02-20 西奈山医学院 流感病毒疫苗及其应用
CA2842860A1 (fr) 2011-07-28 2013-01-31 Sea Lane Biotechnologies, Llc Proteines se liant a sur dirigees contre erbb3
EP4241785B1 (fr) 2011-09-20 2026-01-28 Icahn School of Medicine at Mount Sinai Vaccins contre le virus de la grippe et leurs utilisations
EP2793940B1 (fr) 2011-12-22 2018-11-14 i2 Pharmaceuticals, Inc. Protéines substitutives de liaison
US9969794B2 (en) 2012-05-10 2018-05-15 Visterra, Inc. HA binding agents
CA2895508A1 (fr) 2012-12-18 2014-06-26 Icahn School Of Medicine At Mount Sinai Vaccins contre le virus de la grippe et leurs utilisations
WO2014159960A1 (fr) 2013-03-14 2014-10-02 Icahn School Of Medicine At Mount Sinai Anticorps contre l'hémagglutinine du virus de la grippe et utilisations correspondantes
US10736956B2 (en) 2015-01-23 2020-08-11 Icahn School Of Medicine At Mount Sinai Influenza virus vaccination regimens
US10513553B2 (en) 2015-11-13 2019-12-24 Visterra, Inc. Compositions and methods for treating and preventing influenza
EP3419663A1 (fr) 2016-02-24 2019-01-02 Visterra, Inc. Formulations de molécules d'anticorps contre le virus de la grippe
EP3471767A4 (fr) 2016-06-15 2020-01-15 Icahn School of Medicine at Mount Sinai Hémagglutinines du virus de la grippe et utilisations de celles-ci
WO2018187706A2 (fr) 2017-04-07 2018-10-11 Icahn School Of Medicine At Mount Sinai Anticorps anti-neuraminidase du virus influenza de type b et leurs utilisations
WO2019246363A1 (fr) 2018-06-21 2019-12-26 Icahn School Of Medicine At Mount Sinai Polypeptides d'hémagglutinines du virus de la grippe en mosaïque et leurs utilisations
WO2020198329A1 (fr) 2019-03-25 2020-10-01 Visterra, Inc. Compositions et méthodes pour traiter et prévenir la grippe

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI83662C (fi) * 1980-07-17 1991-08-12 Scripps Clinic Res Diagnostik antikropp och foerfarande foer dess framstaellning.

Also Published As

Publication number Publication date
WO1984000687A1 (fr) 1984-03-01
ES525088A0 (es) 1985-06-16
IL69556A0 (en) 1983-11-30
PH18872A (en) 1985-10-21
DK203684A (da) 1984-04-18
NO161002C (no) 1989-06-21
FI841583A0 (fi) 1984-04-19
NO841540L (no) 1984-04-17
GR78931B (fr) 1984-10-02
DK203684D0 (da) 1984-04-18
ES8505819A1 (es) 1985-06-16
IT8348868A0 (it) 1983-08-22
EP0116629A1 (fr) 1984-08-29
FI841583L (fi) 1984-04-19
JPS59501714A (ja) 1984-10-11
IT1168636B (it) 1987-05-20
IT8348868A1 (it) 1985-02-22
NO161002B (no) 1989-03-13
PT77230B (en) 1986-02-04
KR840006198A (ko) 1984-11-22
EP0116629A4 (fr) 1987-06-29
PT77230A (en) 1983-09-01
IL69556A (en) 1988-05-31
AU1947183A (en) 1984-03-07
NZ220612A (en) 1988-07-28
NZ205341A (en) 1988-07-28
FI841583A7 (fi) 1984-04-19
ZA836080B (en) 1984-04-25

Similar Documents

Publication Publication Date Title
AU570929B2 (en) Broad spectrum influenza antisera
US4625015A (en) Broad spectrum influenza antisera
Katz et al. Efficacy of inactivated influenza A virus (H3N2) vaccines grown in mammalian cells or embryonated eggs
US10137190B2 (en) Nucleic acid molecules encoding ferritin-hemagglutinin fusion proteins
Kodihalli et al. Selection of a single amino acid substitution in the hemagglutinin molecule by chicken eggs can render influenza A virus (H3) candidate vaccine ineffective
US5136019A (en) Synthetic peptides for diagnosis and prevention of influenza virus infection and their use
CA2950085A1 (fr) Trimeres stabilises de la region tige de l'hemagglutinine du virus de la grippe et leurs utilisations
AU650911B2 (en) Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus
US20120014972A1 (en) Influenza virus compositions and methods for universal vaccines
CN105418738B (zh) 口蹄疫病毒a型抗原多肽、融合抗原多肽及疫苗
US5243030A (en) Conjugates of a synthetic peptide for diagnosis and prevention of influenza virus infection
Hackett et al. A synthetic decapeptide of influenza virus hemagglutinin elicits helper T cells with the same fine recognition specificities as occur in response to whole virus.
CN102397559B (zh) 广谱型流感疫苗及其制备方法
Petrov et al. Influenza virus antigens conjugated with a synthetic polyelectrolyte: a novel model of vaccines
Nagy et al. The intersubunit region of the influenza virus haemagglutinin is recognized by antibodies during infection
CN102775478B (zh) 口蹄疫病毒抗原多肽及疫苗
EP1476182A1 (fr) Formulations immunogeniques d'epitopes peptidiques variables et procede de preparation
EP0370090A1 (fr) Immunogenes et peptides biologiquement actifs derives de sequences partagees d'antigenes et d'anticorps anti-idiotypiques ou d'anticorps specifiques contre des recepteurs cellulaires des antigenes.
TW201100094A (en) An antigenic peptide derived from influenza virus and a method for selecting anti-influenza virus antibody
CN101087808A (zh) 流行性感冒病毒蛋白质的组合物及其使用方法
CN120586030A (zh) 一种多价克里米亚刚果出血热mRNA疫苗及其制备方法与应用
JP2004520331A (ja) 日本脳炎ウイルスに対するキメラｔヘルパー細胞−ｂ細胞ペプチドワクチン
CN114053400A (zh) 一种预防新型冠状病毒肺炎covid-19的疫苗及其制备方法
US20140154282A1 (en) Conjugates utilizing platform technology for stimulating immune response
Eisenlohr The antigen processing of influenza virus: Cellular mechanisms exploited by the virus during infection are part of the antigen-processing machinery